Pd L1 Inhibition News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biagio Ricciuti, MD, discusses the association between PD-L1 expression levels and long-term survival with anti–PD-L1 monotherapy in patients with advanced non–small cell lung cancer.

Biagio ricciutiDana farber cancer instituteDepartment of medicinePatients with her2 mutant non small cell lung cancerPd l1 inhibitionLong term survival